Susquehanna International Group, LLP Amarin Corp Plcuk Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.57 - $0.8 $17,499 - $24,560	-30,700 Reduced 44.82%	37,800 $23,000
Q2 2024 Aug 15, 2024	SELL	$0.63 - $1.07 $75,852 - $128,828	-120,400 Reduced 63.74%	68,500 $47,000
Q1 2024 May 07, 2024	BUY	$0.82 - $1.35 $53,956 - $88,830	65,800 Added 53.45%	188,900 $168,000
Q4 2023 Feb 14, 2024	SELL	$0.66 - $0.91 $86,064 - $118,664	-130,400 Reduced 51.44%	123,100 $107,000
Q3 2023 Nov 14, 2023	BUY	$0.85 - $1.43 $19,210 - $32,318	22,600 Added 9.79%	253,500 $233,000
Q2 2023 Aug 11, 2023	SELL	$1.12 - $1.49 $48,272 - $64,219	-43,100 Reduced 15.73%	230,900 $274,000
Q1 2023 May 16, 2023	SELL	$1.19 - $2.19 $629,510 - $1.16 Million	-529,000 Reduced 65.88%	274,000 $411,000
Q4 2022 Feb 14, 2023	SELL	$1.07 - $1.34 $336,729 - $421,698	-314,700 Reduced 28.16%	803,000 $971,000
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $657,488 - $1.01 Million	603,200 Added 117.24%	1,117,700 $1.22 Million

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.